Delivery Order SPE2DB20D3103-SPE2DB23FN5E4

Award Date 5/25/23
Potential Completion Date 5/26/23
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,464.38, is for the delivery of Meropenem-0.9% Sodium Chloride 1 Gram/50s, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,196.33 firm fixed-price delivery order is for the supply of Meropenem-0.9% Sodium Chloride 1 gram/50 units, a critical antibiotic medication. The contract has a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,746.66, is for the supply of 4567008715 - Meropenem-0.9% Sodium Chloride 1 Gram/50s. The contract is a firm fixed-price award with an ultimate completion date of January 23, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
The U.S. government has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,464.38, is for the provision of MEROPENEM-0.9% NACL 1 GRAM/50S medical supplies. The contract has an ultimate completion date of January 31, 2025 and utilizes a firm fixed price pricing type. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,464.38, is for the delivery of Meropenem-0.9% Sodium Chloride, a medication used to treat bacterial infections. The contract has a firm fixed-price pricing type and an ultimate completion date of February 4, 2025. There was no set-aside designation for this award. This contract appears to be a task...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of 4,563,697,433 units of the pharmaceutical drug meropenem, a 2 gram vial. The contract has a total potential value of $2,440.78 and a completion date of February 20, 2024. This delivery order contract is not...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,991.42 order is for the supply of MEROPENEM-0.9% sodium chloride 1 gram/50 single-dose vials, with a performance completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has an established track record of providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,672.97 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 GM/50 ML, a pharmaceutical product. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,547.28 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic ertapenem. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.70 firm fixed-price delivery order is funded by the DLA, an agency under the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN5E4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,098.80 firm fixed-price delivery order is for the supply of 4561053561 - Meropenem-0.9% Sodium Chloride 1 Gram/50s, a specialty medication.

The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This delivery order does not have a set-aside designation, indicating open competition. The contract is set to be completed by May 26, 2023.

Generated 2/27/25, 12:50 PM